[go: up one dir, main page]

UA50728C2 - Спосіб стимуляції імунної системи за допомогою димеру лізоциму - Google Patents

Спосіб стимуляції імунної системи за допомогою димеру лізоциму

Info

Publication number
UA50728C2
UA50728C2 UA97063430A UA97063430A UA50728C2 UA 50728 C2 UA50728 C2 UA 50728C2 UA 97063430 A UA97063430 A UA 97063430A UA 97063430 A UA97063430 A UA 97063430A UA 50728 C2 UA50728 C2 UA 50728C2
Authority
UA
Ukraine
Prior art keywords
lysozyme dimer
immunostimulation
weight
specific
lysozyme
Prior art date
Application number
UA97063430A
Other languages
English (en)
Russian (ru)
Inventor
Вітольд КІЦКА
Original Assignee
Ніка Хелс Продакс Лімітед
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ніка Хелс Продакс Лімітед filed Critical Ніка Хелс Продакс Лімітед
Publication of UA50728C2 publication Critical patent/UA50728C2/uk

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46Hydrolases (3)
    • A61K38/47Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/14Drugs for dermatological disorders for baldness or alopecia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/06Free radical scavengers or antioxidants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Urology & Nephrology (AREA)
  • Virology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Communicable Diseases (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Fish Paste Products (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Винахід стосується фармацевтичних композицій, які містять димер лізоциму, бажано якомога більш високої чистоти, наприклад із вмістом побічних продуктів менше 10% за масою. Описано також нові способи застосування таких композицій, зокрема місцевий, пероральний чи парентеральний з метою неспецифічної імуностимуляції для профілактики та/або лікування онкологічних захворювань, порушення росту волосся. Засіб може використовуватись також для лікування хвороб риб та бджіл. Неспецифічна стимуляція імунної системи індукується одноразовим чи повторним застосуванням композиції димера лізоциму, бажано в концентраціях 5-500 мкг/кг маси тіла.
UA97063430A 1995-01-13 1996-01-13 Спосіб стимуляції імунної системи за допомогою димеру лізоциму UA50728C2 (uk)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP95100446 1995-01-13
EP95110638 1995-07-07
PCT/EP1996/000135 WO1996021463A2 (en) 1995-01-13 1996-01-13 New applications of lysozyme dimer

Publications (1)

Publication Number Publication Date
UA50728C2 true UA50728C2 (uk) 2002-11-15

Family

ID=26138401

Family Applications (1)

Application Number Title Priority Date Filing Date
UA97063430A UA50728C2 (uk) 1995-01-13 1996-01-13 Спосіб стимуляції імунної системи за допомогою димеру лізоциму

Country Status (37)

Country Link
EP (2) EP1086703A3 (uk)
JP (1) JPH10511974A (uk)
KR (1) KR100420377B1 (uk)
CN (1) CN1090506C (uk)
AP (2) AP628A (uk)
AT (1) ATE218367T1 (uk)
AU (1) AU709620B2 (uk)
BA (1) BA96074A (uk)
BG (1) BG62239B1 (uk)
BR (1) BR9606973A (uk)
CA (1) CA2210091A1 (uk)
CZ (1) CZ293353B6 (uk)
DE (2) DE69621589D1 (uk)
DZ (1) DZ1964A1 (uk)
EA (1) EA001462B1 (uk)
EE (1) EE9700154A (uk)
ES (1) ES2109208T1 (uk)
FI (1) FI972943A7 (uk)
GB (1) GB2311724B (uk)
GE (1) GEP20012571B (uk)
GR (1) GR970300047T1 (uk)
HR (1) HRP960014A2 (uk)
HU (1) HU223903B1 (uk)
IL (1) IL116737A (uk)
MA (1) MA23775A1 (uk)
MD (1) MD1633C2 (uk)
MY (1) MY132437A (uk)
NO (1) NO973203L (uk)
NZ (1) NZ298432A (uk)
OA (1) OA10436A (uk)
PL (1) PL185678B1 (uk)
SK (1) SK94297A3 (uk)
SV (1) SV1996000001A (uk)
TN (1) TNSN96004A1 (uk)
TR (1) TR199700633T1 (uk)
UA (1) UA50728C2 (uk)
WO (1) WO1996021463A2 (uk)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6123937A (en) * 1997-03-14 2000-09-26 Nika Health Products, Limited Applications of lysozyme dimer
SI1073448T1 (en) * 1998-04-27 2002-06-30 Nika Health Products Limited Fertility improving composition and application thereof
AUPP489798A0 (en) * 1998-07-28 1998-08-20 Mediko Pty Ltd Hair growth/maintenance compositions and methods
EP2134354A4 (en) * 2007-03-02 2012-03-21 Saint Simeon Lda COMPOSITION AND METHOD FOR THE TREATMENT OF PAPILLOMA VIRUS AND HORSE SARCODES
CN103518978B (zh) * 2013-10-22 2016-01-13 上海艾魁英生物科技有限公司 新型溶菌酶制剂及其制备方法
PL3082837T3 (pl) * 2013-12-18 2021-02-08 Dsm Ip Assets B.V. Kompozycje zawierające hydrolizat lizozymu do zastosowania w tkance zawierającej keratynę
CN104585546B (zh) * 2015-01-20 2019-02-05 上海海洋大学 一种促生长抗应激罗非鱼饲料及其制备方法
CN105707509B (zh) * 2016-01-25 2018-12-28 浙江艾杰斯生物科技有限公司 一种用于防治草鱼烂腮病的饲料添加剂
WO2020099556A1 (en) 2018-11-14 2020-05-22 Universiteit Antwerpen Oxidized lysozyme
US20220273733A1 (en) * 2019-07-26 2022-09-01 Evolve Biosystems, Inc. Nutritive compositions with bioactive proteins
CN111657407A (zh) * 2020-05-14 2020-09-15 上海艾魁英生物科技有限公司 提高断奶仔猪非特异性免疫功能的饲料添加剂、其制备方法和应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5533408A (en) * 1978-08-30 1980-03-08 Eisai Co Ltd Immunity-increasing agent
JPS5543040A (en) * 1978-09-25 1980-03-26 Eisai Co Ltd Immunity raising agent
DE3230999A1 (de) * 1982-08-20 1984-02-23 Philips Kommunikations Industrie AG, 8500 Nürnberg Verfahren zur zugriffssteuerung bei einem nachrichtensystem
JPS61158793A (ja) * 1984-11-14 1986-07-18 Takeda Chem Ind Ltd ヒト・リゾチ−ムの合成遺伝子
RU2061496C1 (ru) * 1985-08-02 1996-06-10 Институт общей патологии и экологии человека Средство, стимулирующее эритропоэз
AU1366088A (en) * 1987-01-28 1988-08-24 Ortho Pharmaceutical Corporation Immunosuppressive peptides and methods of use
US5200182A (en) * 1988-05-26 1993-04-06 Nika Health Products, Ltd. Antiviral or antibacterial composition and method of use
MC2243A1 (fr) * 1990-01-08 1993-02-23 Nika Health Products Ltd Procede de preparation de dimeres de la ribonuclease
RU2067617C1 (ru) * 1990-01-08 1996-10-10 Ника Хелт Продактс Лтд. Способ получения димера лизоцима
PL173978B1 (pl) * 1992-07-13 1998-05-29 Nika Health Products Ltd Sposób oddziaływania na wydzielanie cytokin w hodowli limfocytów krwi obwodowej
RU2082413C1 (ru) * 1993-06-30 1997-06-27 Нижегородский государственный медицинский институт Способ лечения язвенной болезни двенадцатиперстной кишки
RU2071339C1 (ru) * 1994-07-25 1997-01-10 Щербакова Элеонора Григорьевна Средство для лечения и профилактики дисбактериоза
RU2123345C1 (ru) * 1997-07-31 1998-12-20 Научно-исследовательский институт детского питания Российской Академии сельскохозяйственных наук Средство для лечения дисбактериоза

Also Published As

Publication number Publication date
PL185678B1 (pl) 2003-07-31
SK94297A3 (en) 1998-01-14
MY132437A (en) 2007-10-31
CN1177303A (zh) 1998-03-25
HUP9801689A3 (en) 2000-07-28
AP871A (en) 2000-09-10
GEP20012571B (en) 2001-11-26
MD970244A (en) 1999-05-31
AP9600783A0 (en) 1996-04-30
CZ293353B6 (cs) 2004-04-14
TNSN96004A1 (fr) 2005-03-15
HRP960014A2 (en) 1997-12-31
AU4391696A (en) 1996-07-31
WO1996021463A2 (en) 1996-07-18
DZ1964A1 (fr) 2002-10-15
NZ298432A (en) 2001-03-30
ES2109208T1 (es) 1998-01-16
FI972943L (fi) 1997-07-11
DE69621589D1 (de) 2002-07-11
FI972943A0 (fi) 1997-07-11
EP0804227A2 (en) 1997-11-05
AP628A (en) 1998-02-27
SV1996000001A (es) 1997-02-17
BG101709A (en) 1998-03-31
EP1086703A3 (en) 2001-05-02
EE9700154A (et) 1997-12-15
GB2311724B (en) 1999-07-21
CZ220297A3 (cs) 1998-02-18
DE804227T1 (de) 1998-04-09
EP1086703A2 (en) 2001-03-28
BA96074A (bs) 1999-08-02
NO973203D0 (no) 1997-07-10
HK1002060A1 (en) 1998-07-31
EP0804227B1 (en) 2002-06-05
FI972943A7 (fi) 1997-07-11
GB2311724A (en) 1997-10-08
MD1633C2 (ro) 2001-10-31
KR19980701337A (ko) 1998-05-15
AP9701024A0 (en) 1997-07-31
GB9714354D0 (en) 1997-09-10
JPH10511974A (ja) 1998-11-17
EA199700101A1 (ru) 1997-12-30
HU223903B1 (hu) 2005-03-29
HUP9801689A2 (hu) 1998-10-28
NO973203L (no) 1997-07-10
WO1996021463A3 (en) 1996-09-19
TR199700633T1 (xx) 1998-01-21
AU709620B2 (en) 1999-09-02
BR9606973A (pt) 1999-01-26
MA23775A1 (fr) 1996-10-01
OA10436A (en) 2001-12-07
BG62239B1 (bg) 1999-06-30
ATE218367T1 (de) 2002-06-15
GR970300047T1 (en) 1997-12-31
IL116737A0 (en) 1996-05-14
MD1633B2 (en) 2001-03-31
CA2210091A1 (en) 1996-07-18
CN1090506C (zh) 2002-09-11
KR100420377B1 (ko) 2004-05-20
IL116737A (en) 2000-02-17
PL321546A1 (en) 1997-12-08
EA001462B1 (ru) 2001-04-23

Similar Documents

Publication Publication Date Title
HUT54060A (en) Process for producing pharmaceutical compositions with antiviral or antibacterial effect
MY101842A (en) Treatment of oral diseases.
MX9702932A (es) L-ribofuranosilnucleosidos.
MX9604378A (es) Amidas de acido quinolin-2-carboxilico sustituidas, su preparacion y su empleo como medicamentos, asi como productos intermedios.
MX9203050A (es) Compuestos de analogos de triptamina.
PT76502A (en) Process for the preparation of n-glycosylated carboxamide derivatives with s stimulating effect of the body's inherent defences and their application for the preparation of pharmaceutical compositions having a stimulating effect of body's inherent defences
UA50728C2 (uk) Спосіб стимуляції імунної системи за допомогою димеру лізоциму
AU7827587A (en) Methods and agents for removing advanced glycosylation endproducts
ATE229809T1 (de) Verwendung von magnesium enthaltenden verbindungen zur behandlung oder prophylaxe von krebs- und autoimmunkrankheiten
DE69521536D1 (de) Zusammensetzungen die G-CSF und ein TNF-Bindungsprotein enthalten
BG105275A (en) Tan-1057 derivatives
MX9702926A (es) L-eritrosilnucleosidos.
IL118218A0 (en) Terpenoidic derivatives and pharmaceutical compositions containing them
MX9304925A (es) Composiciones terapeuticas contra el cancer para profilaxis o para el tratamiento de cancer.
MX9702927A (es) L-piranosilnucleosidos.
MX9705246A (es) Nuevas aplicaciones de dimero de lisozina.
JO1898B1 (en) New uses of the partial formula partial lysozyme
EA199800941A1 (ru) Терапевтические средства, содержащие кислородные анион-радикалы и/или продукты их последующего превращения и расщепления, и их применение для лечения болезни паркинсона
MD218C2 (ro) Stimulant pentru creşterea părului
GEP19971029B (en) Antiviral or antibacterial compound and method of use thereof
MY106984A (en) Antiviral or antibacterial composition and method of use.